Primary Retinal Detachment

More documents

Recommendations

Info

156 7 Pharmacological Approaches to Improve Surgical Outcomes 5. Cowley M, Conway B, Campochiaro P, Kaiser D, Gaskin H (1989) Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 107:1147–1151 6. Grizzard WS, Hilton GF (1982) Scleral buckling for retinal detachments complicated by periretinal proliferation.Arch Ophthalmol 100: 419–422 7. Sternberg P Jr, Machemer R (1985) Results of conventional vitreous surgery for proliferative vitreoretinopathy. Am J Ophthalmol 100: 141–146 8. Blumenkranz M, Hernandez E, Ophir A, Norton EWD (1984) 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91:122– 130 9. Blumenkranz MS (1988) Management of complicated retinal detachment. In: Tso MOM (ed) <strong>Retinal</strong> diseases: biomedical foundations and clinical management. JB Lippincott, Philadelphia 10. Asaria RH, Kon CH, Bunce C, Charteris DC et al (2001) How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology 108:1184–1186 11. Martidis A, Duker JS, Greenberg PB, Rogers AH et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927 12. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86:247–248 13. Koerner F, Merz A, Gloor B, Wagner E (1982) Postoperative retinal fibrosis – a controlled clinical study of systemic steroid therapy. Graefes Arch Clin Exp Ophthalmol 219:268–271 14. Machemer R (1977) Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 75:556–586 15. Blumenkranz MS, Hartzer MK (2000) The mechanism of action of drugs for the treatment of vitreoretinal scarring. In: Retina, vol. 3. Ryan S, Glaser B (eds) CV Mosby, St. Louis, pp 2281–2293 16. Campochiaro PA, Bryan JA III, Conway BP, Jaccoma EH (1986) Intravitreal chemotactic and mitogenic activity implications of bloodretinal barrier breakdown. Arch Ophthalmol 104:1685–1687 17. Campochiaro PA, Glaser BM (1986) Mechanisms involved in retinal pigment epithelial cell chemotaxis. Arch Ophthalmol 104: 277–280
References 157 18. Yeo JH, Sadeghi J, Campochiaro PA, Green WR, Glaser BM (1986) Intravitreous fibronectin and platelet-derived growth factor: new model for tractional retinal detachment.Arch Ophthalmol 104:417–421 19. Verdoorn C, Renardel de Lavalette VW, Dalma-Weizhaus J, Orr GM, Sorgente N, Ryan SJ (1986) Cellular migration, proliferation and contraction: an in vitro approach to a clinical problem – proliferative vitreoretinopathy. Arch Ophthalmol 104:1216–1219 20. Vidaurri-Leal J, Glaser B (1984) Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol 102:1376–1379 21. Vidaurri-Leal J, Hohman R, and Glaser BM (1984) Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells: a new approach to the study of proliferative vitreoretinopathy. Arch Ophthalmol 102:1220–1223 22. Blumenkranz MS, Ophir A, Claflin A, Hajek AS (1982) Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94:458–467 23. Stern WH, Lewis GP, Erickson PA, Guerin CJ,Anderson DH, Fisher SK, O’Donnell JJ (1983) Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol 96:33–42 24. Tano Y, Sugita G, Abrams G, Machemer R (1980) Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol 89:131–136 25. Van Bockxmeer FM, Martin CE, Constable IJ (1985) Models for assessing scar tissue inhibitors. Retina 5:47–60 26. Wiedemann P, Lemmen K, Schmiedl R, Heimann K (1987) Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol 104:10–14 27. Anonymous (1992) Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 110:770–779 28. Anonymous (1992) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 110:780–792 29. Jolimaitre P, Malet-Martino M, Martino R (2003) Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release fluorouracil. Int J Pharm 259:181–192
Page 2 and 3:
Ingrid Kreissig (Ed.) Primary Retin
Page 4 and 5:
Professor Dr. med. Ingrid Kreissig
Page 6 and 7:
Contents 1 The History of Retinal D
Page 8 and 9:
List of Contributors Gary W. Abrams
Page 10 and 11:
List of Contributors XI Hermann D.
Page 12 and 13:
2 Helmholz in 1850 made an accurate
Page 14 and 15:
4 (vitreous, gelatin) into the ante
Page 16 and 17:
6 with scleral resection that set t
Page 18 and 19:
8 ditis [72-74].Temperatures up to
Page 20 and 21:
10 1 The History of Retinal Detachm
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
16 ion [147]. Perfluorocarbon liqui
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
26 2 Prophylaxis in Fellow Eye of P
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
32 found that eyes with pre-existin
Page 44 and 45:
Page 46 and 47:
36 3 Encircling Operation with Drai
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Chapter 4 Pneumatic Retinopexy for
Page 66 and 67:
Technique 57 Case Selection Proper
Page 68 and 69:
Technique 59 Table 4.1. Gas charact
Page 70 and 71:
Technique 61 solution; however,thes
Page 72 and 73:
Technique 63 gas reflux. Following
Page 74 and 75:
Complications: Prevention and Manag
Page 76 and 77:
New Possibilities 67 ing on type an
Page 78 and 79:
Results 69 Table 4.7 (continued) Au
Page 80 and 81:
Discussion 71 surgical failures. Fa
Page 82 and 83:
Discussion 73 Disadvantages of PR A
Page 84 and 85:
References 75 situations, then to p
Page 86 and 87:
References 77 24. Tornambe PE, Hilt
Page 88 and 89:
References 79 51. Pournaras CJ, Don
Page 90 and 91:
Chapter 5 Vitrectomy for the Primar
Page 92 and 93:
Indications 83 Table 5.1. Indicatio
Page 94 and 95:
Indications 85 Fig. 5.2. The vitreo
Page 96 and 97:
Surgical Technique 87 vitrectomy an
Page 98 and 99:
Outcomes 89 will be visible under a
Page 100 and 101:
Outcomes 91 almost no persistent su
Page 102 and 103:
References 93 7. Heimann H, Bornfel
Page 104 and 105:
96 6 Minimal Segmental Buckling Wit
Page 106 and 107:
98 6 Minimal Segmental Buckling Wit
Page 108 and 109:
100 the operating table with the re
Page 110 and 111:
102 6 Minimal Segmental Buckling Wi
Page 112 and 113:
104 6 Minimal Segmental Buckling Wi
Page 114 and 115: 106 a b 6 Minimal Segmental Bucklin
Page 118 and 119: 110 6 Minimal Segmental Buckling Wi
Page 122 and 123: 114 a 6 Minimal Segmental Buckling
Page 130 and 131: 122 c d 6 Minimal Segmental Bucklin
Page 132 and 133: 124 c Fig. 6.14c 6 Minimal Segmenta
Page 134 and 135: Table 6.1. Preoperative characteris
Page 136 and 137: Table 6.3. Final attachment after m
Page 138 and 139: 130 Choroidals In 4 of the 1,462 de
Page 140 and 141: Table 6.4. Visual acuity at 2 years
Page 148 and 149: 140 Probably, the future question n
Page 154 and 155: 146 7 Pharmacological Approaches to
Page 160 and 161: 152 heparin was published in eyes u
Page 162 and 163: 154 search for compounds with hepar
Page 168 and 169: Chapter 8 Systematic Review of Effi
Page 170 and 171: Materials and Methods 163 Table 8.2
Page 172 and 173: Discussion 165 30% 25% 20% 15% 10%
Page 174 and 175: Discussion 167 Fig. 8.2. The small
Page 176 and 177: Conclusion 169 vitrectomy and searc
Page 178 and 179: References 171 8. Brazitikos PD, D
Page 180 and 181: References 173 34. Gunduz K, Gunalp
Page 182 and 183: References 175 63. Schepens CL (195
Page 184 and 185: 178 9 Repair of Primary Retinal Det
Page 186 and 187: 180 a b Fig. 9.3a,b. Legend see pag
Page 192 and 193: 186 a b 9 Repair of Primary Retinal
Page 194 and 195: 188 might eliminate traction on the
Page 198 and 199: Chapter 10 Retinal Detachment Repai
Page 200 and 201: Retinal Detachment Repair: Outlook
Page 212 and 213: References 207 It is impossible to
Page 214 and 215:
210 C Campbell 7 case selection 57,
Page 216 and 217:
212 M Machemer 13 macular - complic
Page 218 and 219:
214 retinal - detachment - - bilate
show all

Primary Retinal Detachment

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?